COVID-19 Drug Development

This book focuses on providing possible solutions to the ongoing COVID-19 pandemic in light of these advances in life sciences.

COVID-19 is a rampant worldwide problem. It is caused by the SARS-CoV-2 virus and is manifest in different variants. The Delta variant compromised existing therapeutic and preventive options for this disease and is beginning to be replaced by the Omicron variant. Through pharmaceutical biotechnology, three different treatment approaches to COVID-19 have been developed: computer-aided drug design (CADD); rational drug design in the wet lab; and the advanced drug delivery system. These approaches are heavily influenced by advances in life sciences, such as the development of structural bioinformatics, the establishment of nanobiotechnology as a standard approach in drug design, and major advances in structural biology such as the development of the CryoEM method.

Contents
1. Current Perspective of COVID-19 Drugs
2. Pluralism Medical Treatment, Prevention, and Control of COVID-19 Infection and Its Long-Sufferings among the Older Adults in the Northeast of Thailand from 2019 to 2022
3. Baricitinib in the Treatment of COVID-19
4. New Perspective and Applications of Homeopathy in Treating COVID-19 Symptoms
5. Treatments for the Infection by SARS-CoV-2
6. Inclusive Review on Existing Treatment and Management Modalities for COVID-19
7. COVID-19: From Pathophysiology to Treatment
8. COVID-19 Drug Development: Role of Drug Repurposing